Omnicell (OMCL) Liabilities and Shareholders Equity (2010 - 2026)

Omnicell (OMCL) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $2.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 6.83% year-over-year to $2.0 billion in Q2 2026; TTM through Jun 2026 was $7.9 billion, a 9.12% decrease from a year earlier, with the FY2025 full-year figure at $2.0 billion, down 6.89% from the prior year.
• Liabilities and Shareholders Equity was $2.0 billion for Q2 2026 at Omnicell, roughly flat from $2.0 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $2.3 billion in Q3 2024 and troughed at $1.9 billion in Q3 2025.
• A 5-year average of $2.2 billion and a median of $2.2 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity gained 12.51% in 2022 and retreated 15.41% in 2025, its largest moves.
• Over 5 years, Liabilities and Shareholders Equity stood at $2.2 billion in 2022, then advanced by 0.73% to $2.2 billion in 2023, then dropped by 4.76% to $2.1 billion in 2024, then decreased by 6.89% to $2.0 billion in 2025, then grew by 1.22% to $2.0 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $2.0 billion (Q2 2026), $2.0 billion (Q1 2026), and $2.0 billion (Q4 2025), per Business Quant data.